Home Trials Current Trials AFFINITY: Assessment of fluoxetine in stroke recovery trial

AFFINITY: Assessment of fluoxetine in stroke recovery trial

E-mail Print PDF

Lead PI:  Graeme J Hankey and Maree L. Hackett

Status: Recruiting

No. of Patients Currently Recruited: 389                                No. of Patients Required:  1600

An Australian-lead investigator initiated, multi-centre, prospective, randomized, parallel group, double blind placebo-controlled trial to establish the effect(s) of routine administration of fluoxetine (20mg once daily) for 6 months in patients with recent stroke on functional outcome at 6 months and one year.

Setting: Stroke Units in Australia, New Zealand and Vietnam

Primary Aim: Does treatment with fluoxetine, 20 mg once daily, started 2-15 days after stroke onset and continued for 180 days, improve functional outcome at 180 days after randomisation?

Trial URL:

ANZCTR No: ACTRN12611000774921

https://www.affinitytrial.org

http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-0864-1

Last Updated ( Wednesday, 10 January 2018 12:43 )  


ASTN Latest news

Top Views